Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Aparicio

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Breast Cancer Research : BCR|December 10, 2009
Human mammary cancer progression model recapitulates methylation events associated with breast premalignancyNancy Dumont, Yongping G Crawford, Mahvash Sigaroudinia, et al.
Nature Genetics|April 19, 2022
Breast tumor microenvironment structures are associated with genomic features and clinical outcomeEsther Danenberg, Helen Bardwell, Vito R T Zanotelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevanceLaxmi Silwal-Pandit, Hans Kristian Moen Vollan, Suet-Feung Chin, et al.
Nature Communications|October 6, 2015
Systematic analysis of somatic mutations impacting gene expression in 12 tumour typesJiarui Ding, Melissa K McConechy, Hugo M Horlings, et al.
Plos One|March 4, 2016
Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In VitroAda W Y Leung, Stacy S Hung, Ian Backstrom, et al.
Genome Biology|March 15, 2019
clonealign: statistical integration of independent single-cell RNA and DNA sequencing data from human cancersKieran R Campbell, Adi Steif, Emma Laks, et al.
Genome Research|May 29, 2012
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancerGavin Ha, Andrew Roth, Daniel Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2016
Robust high-performance nanoliter-volume single-cell multiple displacement amplification on planar substratesKaston Leung, Anders Klaus, Bill K Lin, et al.
Molecular Cancer Research : MCR|August 6, 2013
TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cellsHok Khim Fam, Cheryl Walton, Sheetal A Mitra, et al.
Breast Cancer Research : BCR|September 19, 2007
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapyAnna L Stratford, Golareh Habibi, Arezoo Astanehe, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Breast Cancer Research : BCR|December 10, 2009
Human mammary cancer progression model recapitulates methylation events associated with breast premalignancyNancy Dumont, Yongping G Crawford, Mahvash Sigaroudinia, et al.
Nature Genetics|April 19, 2022
Breast tumor microenvironment structures are associated with genomic features and clinical outcomeEsther Danenberg, Helen Bardwell, Vito R T Zanotelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevanceLaxmi Silwal-Pandit, Hans Kristian Moen Vollan, Suet-Feung Chin, et al.
Nature Communications|October 6, 2015
Systematic analysis of somatic mutations impacting gene expression in 12 tumour typesJiarui Ding, Melissa K McConechy, Hugo M Horlings, et al.
Plos One|March 4, 2016
Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In VitroAda W Y Leung, Stacy S Hung, Ian Backstrom, et al.
Genome Biology|March 15, 2019
clonealign: statistical integration of independent single-cell RNA and DNA sequencing data from human cancersKieran R Campbell, Adi Steif, Emma Laks, et al.
Genome Research|May 29, 2012
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancerGavin Ha, Andrew Roth, Daniel Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2016
Robust high-performance nanoliter-volume single-cell multiple displacement amplification on planar substratesKaston Leung, Anders Klaus, Bill K Lin, et al.
Molecular Cancer Research : MCR|August 6, 2013
TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cellsHok Khim Fam, Cheryl Walton, Sheetal A Mitra, et al.
Breast Cancer Research : BCR|September 19, 2007
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapyAnna L Stratford, Golareh Habibi, Arezoo Astanehe, et al.
Pageof 14